United Theranostics closed a $15 million senior debt facility with Old National Bank. The company will use proceeds from the facility to fund the expansion of its nationwide network of clinics offering patients: approved radiopharmaceutical therapies, and clinical trials for new radiopharmaceutical drugs under investigation.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ONB:
- Old National Bancorp Unveils Q4 2024 Investor Presentation
- Old National Bancorp’s Earnings Call Highlights Growth and Challenges
- Old National Bancorp price target raised to $26 from $24 at RBC Capital
- Old National Bancorp price target raised to $29 from $28 at Raymond James
- Old National Bancorp’s 2024 Earnings Overview